- Disneyland gets final approval for ‘biggest thing’ since its opening CNN
- The Anaheim City Council gave its final approval to the DisneylandForward expansion plan, expected to add new attractions and create jobs. KABC-TV
- Disney receives key approval to expand Southern California theme parks The Hill
- Disneyland Forward receives final approval from Anaheim City Council KTLA Los Angeles
- Disney’s $1.9B DisneylandForward Plan Gets Final Approval From Anaheim City Council; Major Changes Set For Walt’s Original Park Deadline
Tag Archives: approval
Disney’s $1.9B DisneylandForward Plan Gets Final Approval From Anaheim City Council; Major Changes Set For Walt’s Original Park – Deadline
- Disney’s $1.9B DisneylandForward Plan Gets Final Approval From Anaheim City Council; Major Changes Set For Walt’s Original Park Deadline
- Disneyland Forward receives final approval from Anaheim City Council KTLA Los Angeles
- Disneyland’s $1.9 Billion Expansion Plan Officially Approved PEOPLE
- Disneyland intends to spend nearly $2 billion to develop the property over the next decade, including $40 million to buy streets from the city of Anaheim. KABC-TV
- Anaheim City Council gives final approval on Disneyland expansion plan NBC Los Angeles
Beyoncé Given The Country Music Seal Of Approval By Dolly Parton – Deadline
- Beyoncé Given The Country Music Seal Of Approval By Dolly Parton Deadline
- Dolly Parton Congratulates Beyoncé on Hitting No. 1 on Billboard Hot Country Chart, ‘Very Excited’ For Her Full Album PEOPLE
- With Beyoncé’s foray into country music, the genre may finally break free from the stereotypes that have long dogged it The Conversation
- Beyoncé becomes first Black woman to top country charts with “Texas Hold ‘Em” CBS News
- Beyoncé Becomes First Black Woman To Top Country Music Chart With Her Single “Texas Hold ‘Em” Deadline
AstraZeneca’s first-in-class FDA approval for Truqap marred by surprise restriction – FiercePharma
- AstraZeneca’s first-in-class FDA approval for Truqap marred by surprise restriction FiercePharma
- AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment BioSpace
- TRUQAP™ (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer Business Wire
- FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+/HER2– Breast Cancer With PIK3CA, AKT1, or PTEN Alterations OncLive
- FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+, HER2– Breast Cancer Cancer Network
- View Full Coverage on Google News
World’s first CRISPR-based medicine wins approval in U.K. – STAT
- World’s first CRISPR-based medicine wins approval in U.K. STAT
- UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia AOL
- This gene-editing therapy could cure sickle cell disease, and it’s close to FDA approval The Hill
- UK authorises gene therapy for blood disorders in world first Reuters
- Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta T Business Wire
- View Full Coverage on Google News
Biden – with Worst Ever Favorability & Job Approval Ratings – Leads Trump 46-37%; Only Leads By 7 Points if RFK & West Are on Ballot; 52% of Dems Want Party to Nominate Someone other than Biden in ’24 – Siena College Research Institut – Siena College Research Institute
- Biden – with Worst Ever Favorability & Job Approval Ratings – Leads Trump 46-37%; Only Leads By 7 Points if RFK & West Are on Ballot; 52% of Dems Want Party to Nominate Someone other than Biden in ’24 – Siena College Research Institut Siena College Research Institute
- Biden sees record-low favorability, job approval among NY voters: poll The Hill
- Nearly two-thirds of New Yorkers blame Biden for migrant crisis: poll New York Post
- Majority of New Yorkers worry migrant crisis will ‘destroy’ NYC as some sour on Biden in new Siena poll New York Daily News
Grayscale GBTC discount falls to 16% as markets bet on Bitcoin ETF approval – Cointelegraph
- Grayscale GBTC discount falls to 16% as markets bet on Bitcoin ETF approval Cointelegraph
- SEC Has No Plans To Appeal Court Ruling on Grayscale Bitcoin ETF: Report The Daily Hodl
- Spot Bitcoin ETF Approval Is Almost Done Deal, Bloomberg Analysts Argue U.Today
- Bitcoin Price Prediction as BTC Bulls Secure $26,000 Level – Is The Next Leg Up Starting? Cryptonews
- Grayscale’s ETF Ambitions Gain Momentum: SEC Steps Back, But Will Bitcoin Price Rocket to the Moon? CryptoTicker.io – Bitcoin Price, Ethereum Price & Crypto News
- View Full Coverage on Google News
Major Trial Finds MDMA-Assisted Therapy Is Effective for PTSD, Paving Way for FDA Approval – Gizmodo
- Major Trial Finds MDMA-Assisted Therapy Is Effective for PTSD, Paving Way for FDA Approval Gizmodo
- Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval The Associated Press
- MDMA Therapy for PTSD Inches Closer to U.S. Approval The New York Times
- MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study Pharmacy Times
- After Latest Clinical Trial, MDMA Therapy For PTSD Is ‘On Track’ For FDA Consideration Next Year Marijuana Moment
- View Full Coverage on Google News
‘Approval Is Inevitable’—SEC Insider Primes Crypto Market For $15 Trillion Bitcoin, Ethereum And XRP Price ETF Game-Changer – Forbes
- ‘Approval Is Inevitable’—SEC Insider Primes Crypto Market For $15 Trillion Bitcoin, Ethereum And XRP Price ETF Game-Changer Forbes
- SEC vs Grayscale: SEC has ‘variety of options’ to delay Grayscale bitcoin ETF Yahoo Finance
- Crypto market ‘dramatically underestimates’ bullishness of spot Bitcoin ETFs Cointelegraph
- SEC Delays Decision on Latest Bitcoin ETF Applications After Grayscale Victory CoinDesk
- Bitcoin’s Big Day: SEC to Make Historic Decision on October 17 Coinpedia Fintech News
- View Full Coverage on Google News
Grayscale’s Legal Win Versus SEC Makes Spot Bitcoin ETF Approval More Likely: JPMorgan – CoinDesk
- Grayscale’s Legal Win Versus SEC Makes Spot Bitcoin ETF Approval More Likely: JPMorgan CoinDesk
- SEC delays BTC ETF decision, Grayscale triumphs over SEC and BitBoy gets the boot: Hodler’s Digest, Aug. 27 – Sept. 2 Cointelegraph
- JP Morgan believes SEC will be forced to approve ETFs after losing case against Grayscale CryptoSlate
- JPMorgan analysts predict SEC will approve multiple spot bitcoin ETFs following Grayscale’s legal victory – Cryptopolitan Cryptopolitan
- Bitcoin ETF applications: Who is filing and when the SEC may decide Cointelegraph
- View Full Coverage on Google News